Altuna et al. [16] assumed that tyrosinase inhibitor such as imatinib may have therapeutic effect in treating vestibular schwannoma with high expression rate of platelet-derived growth factor receptor (PDGFR) and c-kit. This evidence concerns the gene PDGFRB and Vestibular schwannoma.